With billions in play, opioid settlements turn political
By TERRY LYNAM // To those who’ve lost a loved one, it’s blood money: $55 billion in court settlements to be paid out in response to the 900,000 American lives…
Purdue Pharma
Without gov’t oversight, who watches the pushers?
By TERRY LYNAM // Most people have a negative instinctive reaction to government bureaucracy and regulatory mandates, often viewed as excessively burdensome micromanagement. Many are inarguably flawed – but regulatory…
Oklahoma opioid ruling offers hope to front-lines LI
By KEVIN DAHILL // The $572 million that an Oklahoma judge ordered Johnson & Johnson to pay to the State of Oklahoma for the company’s role in the opioid crisis…
Nerve-stim startup Sanguistat shuffles its deck
By GREGORY ZELLER // A Connecticut-based biotech spun out of the Feinstein Institute for Medical Research has assembled a powerful collection of advisors and directors, including corporate heavyweights and recognized…